Impact of hepatitis C therapy on urinary outcomes and renal function: a prospective real-world cohort study of early kidney changes. [PDF]
Kaartinen K +4 more
europepmc +1 more source
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir. [PDF]
Landry G +10 more
europepmc +1 more source
Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings. [PDF]
Takada H +30 more
europepmc +1 more source
Transition From Interferon-Based Therapy to Direct-Acting Antivirals in Albanian Children With Chronic Hepatitis C: A 17-Year Real-World Experience. [PDF]
Velmishi V +9 more
europepmc +1 more source
Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]
Ruan LM +8 more
europepmc +1 more source
Vanishing Act: Spontaneous Regression of Hepatocellular Carcinoma After Hepatitis C Virus Treatment and Emergent Transjugular Intrahepatic Portosystemic Shunt Placement. [PDF]
MacDonald J +4 more
europepmc +1 more source
Triple infection with pulmonary tuberculosis, chronic hepatitis C and systemic brucellosis in an HIV/AIDS patient: a case report from northwestern China. [PDF]
Han X +5 more
europepmc +1 more source
Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients With Prior DAA Failure: A Retrospective Study From a National Treatment Center. [PDF]
Singh S +6 more
europepmc +1 more source
Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]
Pokorska-Śpiewak M +4 more
europepmc +1 more source

